« Migraine Associated With Increased CVD Risk in Men - Medscape (subscription)
Cholesterol Metabolism Without Oxygen - Medical News Today (press release) »

New data supports safety of anti-anginal drug but not its … - SpiritIndia


SpiritIndia		 New data supports safety of anti-anginal drug but not its …
SpiritIndia, India -Apr 24, 2007
The medication ranolazine is used for patients with chronic angina, but because of an association between ranolazine and prolongation of the QT interval (a …

More: continued here

This entry was posted on Saturday, April 28th, 2007 at 8:04 pm and is filed under Angina. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply

You must be logged in to post a comment.